Why Cal-Maine Foods Shares Are Trading Higher By Around 8%; Here Are 20 Stocks Moving Premarket

Acorda Therapeutics, Inc. 0.00%
Aesthetic Medical International Holdings Group -5.67%
BYND Cannasoft Enterprises Inc Ordinary Shares +13.88%
Cal-Maine Foods, Inc. +2.60%
Citizens Svgs Bk & Tr Co Com +10.42%

ACOR

NaN

Aesthetic Medical International Holdings Group

AIH

0.37

-5.67%

BYND Cannasoft Enterprises Inc Ordinary Shares

BCAN

0.88

+13.88%

Cal-Maine Foods, Inc.

CALM

61.90

+2.60%

Citizens Svgs Bk & Tr Co Com

CISS

1.59

+10.42%

Shares of Cal-Maine Foods, Inc. (NASDAQ:CALM) rose sharply in today’s pre-market trading after the company reported upbeat results for its fourth quarter.

The company reported quarterly earnings of $3.00 per share which beat the analyst consensus estimate of $2.46 per share, according to data from Benzinga Pro.

Cal-Maine Foods shares jumped 8.3% to $63.80 in pre-market trading

Here are some other stocks moving in pre-market trading.

Gainers

  • LAMF Global Ventures Corp. I (NASDAQ:LGVC) rose 148.9% to $26.79 in pre-market trading. ViewLAMF Global Ventures Corp. I shareholders approved previously announced business combination with Nuvo Group Ltd.
  • Aesthetic Medical International Holdings Group Limited (NASDAQ:AIH) gained 68.3% to $0.5389 in pre-market trading after gaining 13% on Tuesday.
  • OneMedNet Corporation (NASDAQ:ONMD) gained 34.1% to $1.06 in pre-market trading. OneMedNet announced it entered a securities purchase agreement dated Mar. 28 providing up to $4.54 million in funding through private placement of senior convertible notes.
  • Vanda Pharmaceuticals Inc. (NASDAQ:VNDA) shares gained 28.1% to $5.01 in pre-market trading. Vanda Pharmaceuticals' Fanapt® received U.S. FDA approval for the acute treatment of Bipolar I Disorder.
  • Inspire Veterinary Partners, Inc. (NASDAQ:IVP) gained 16% to $0.0545 in pre-market trading. On Jan. 5, Inspire Veterinary Partners filed a prospectus related to up to a $5 million public offering.
  • C3is Inc. (NASDAQ:CISS) shares rose 15.6% to $0.0473 in pre-market trading after gaining 13% on Tuesday. On March 26, C3is reported a year-over-year increase in fourth-quarter financial results.
  • Motus GI Holdings, Inc. (NASDAQ:MOTS) climbed 11.1% to $0.50 in pre-market trading after gaining around 3% on Tuesday.
  • Edible Garden AG Incorporated (NASDAQ:EDBL) shares rose 9.2% to $0.3735 in pre-market trading. Edible Garden announced a reverse stock split of the company's common stock.
  • Dave & Buster's Entertainment, Inc. (NASDAQ:PLAY) shares rose 6.3% to $65.81 in pre-market trading after the company reported fourth quarter results.

Losers

  • View, Inc. (NASDAQ:VIEW) declined 61.8% to $0.42 in pre-market trading after the company reached a real with Cantor Fitzgerald and RXR to become a private company.
  • Acorda Therapeutics, Inc. (NASDAQ:ACOR) shares dropped 24% to $1.90 in pre-market trading. Acorda Therapeutics shares dipped 81% on Tuesday after the company commenced voluntary proceedings under Chapter 11 of the United States Bankruptcy Code.
  • HWH International Inc. (NASDAQ:HWH) fell 23.4% to $1.18 in pre-market trading after jumping 63% on Tuesday.
  • Sintx Technologies, Inc. (NASDAQ:SINT) fell 22.5% to $0.0324 in pre-market trading after gaining 5% on Tuesday. SiNtx Technologies recently announced a proposed public offering of common stock.
  • VivoPower International PLC (NASDAQ:VVPR) fell 18.4% to $4.80 pre-market trading. VivoPower shares jumped 304% on Tuesday after the company's Tembo subsidiary announced it will merge with the Nasdaq-listed Cactus Acquisition Corp. 1 Limited.
  • Mesoblast Limited (NASDAQ:MESO) shares tumbled 13.1% to $5.73 in pre-market trading after gaining 8% on Tuesday.
  • BYND Cannasoft Enterprises Inc. (NASDAQ:BCAN) fell 11.1% to $1.12 pre-market trading after dipping around 12% on Tuesday.
  • Gamida Cell Ltd. (NASDAQ:GMDA) shares fell 10% to $0.0396 in pre-market trading after gaining 18% on Tuesday.
  • Fractyl Health, Inc. (NASDAQ:GUTS) fell 9.1% to $6.13 in pre-market trading after declining around 10% on Tuesday. The company recently announced FDA IDE approval for the Revita Remain-1 pivotal study and then rebounded after reporting Q4 financial results.
  • Intel Corporation (NASDAQ:INTC) fell 4.8% to $41.85 in pre-market trading after the company outlined a new financial framework for its foundry business. After the market close on Tuesday, Intel announced a new financial reporting structure designed to drive increased cost discipline and higher returns by providing greater transparency, accountability and incentives across the business.

 

Now Read This: Acuity Brands Likely To Report Higher Q2 Earnings; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts

Every question you ask will be answered
Scan the QR code to contact us
whatsapp
Also you can contact us via